Literature DB >> 23906618

Vitamin D and psychosis: mini meta-analysis.

Martino Belvederi Murri1, Matteo Respino, Mattia Masotti, Marco Innamorati, Valeria Mondelli, Carmine Pariante, Mario Amore.   

Abstract

Individuals with psychotic disorders are more likely to have vitamin D (VD) deficiency, while evidence suggests VD could have pathophysiological roles. We summarized meta-analytically the available evidence on VD levels in psychotic disorders in comparison with healthy controls and other psychiatric illnesses. We found seven studies, all reporting insufficient VD levels in patients with psychosis. Schizophrenia had a medium effect size for lower VD than healthy controls, and a trend for lower levels than other psychoses. There were non-significant differences between schizophrenia and major depression. No study has investigated the potential psychotropic effects of VD supplementation in patients with psychosis.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Psychosis; Schizophrenia; Vitamin D

Mesh:

Year:  2013        PMID: 23906618     DOI: 10.1016/j.schres.2013.07.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  36 in total

1.  Maternal vitamin D status in pregnancy and offspring brain development: the forgotten (but essential) needs of vitamin D era.

Authors:  C Annweiler; O Beauchet
Journal:  Osteoporos Int       Date:  2013-10-18       Impact factor: 4.507

2.  Association of Urbanicity With Psychosis in Low- and Middle-Income Countries.

Authors:  Jordan E DeVylder; Ian Kelleher; Monique Lalane; Hans Oh; Bruce G Link; Ai Koyanagi
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

Review 3.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 4.  Vitamin supplementation in the treatment of schizophrenia.

Authors:  Hannah E Brown; Joshua L Roffman
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

5.  Low vitamin D levels predict clinical features of schizophrenia.

Authors:  Kristina Cieslak; Jordyn Feingold; Daniel Antonius; Julie Walsh-Messinger; Roberta Dracxler; Mary Rosedale; Nicole Aujero; David Keefe; Deborah Goetz; Raymond Goetz; Dolores Malaspina
Journal:  Schizophr Res       Date:  2014-10-11       Impact factor: 4.939

6.  Chronic stress causes neuroendocrine-immune disturbances without affecting renal vitamin D metabolism in rats.

Authors:  P Jiang; L Zhang; W Zhu; H Li; R Dang; M Tang
Journal:  J Endocrinol Invest       Date:  2014-10-16       Impact factor: 4.256

7.  Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.

Authors:  Lirong Wang; Jian Ying; Peihao Fan; Elise A Weamer; Mary Ann A DeMichele-Sweet; Oscar L Lopez; Julia K Kofler; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-27       Impact factor: 4.105

8.  Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.

Authors:  James D Clelland; Laura L Read; Valérie Drouet; Angela Kaon; Alexandra Kelly; Karen E Duff; Robert H Nadrich; Amit Rajparia; Catherine L Clelland
Journal:  Schizophr Res       Date:  2014-04-29       Impact factor: 4.939

9.  Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.

Authors:  G Fond; M Faugere; C Faget-Agius; M Cermolacce; R Richieri; L Boyer; C Lançon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-08-04       Impact factor: 5.270

10.  Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation.

Authors:  Rabia Nazik Yüksel; Neslihan Altunsoy; Baise Tikir; Merve Cingi Külük; Kubranur Unal; Sema Goka; Cigdem Aydemir; Erol Goka
Journal:  Ther Adv Psychopharmacol       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.